Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 67877-511

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 67877-511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin-st (Atorvastatin St)

Chemical structure of Atorvastatin Calcium is shown, depicting the detailed molecular arrangement including multiple phenyl rings, hydroxyl groups, and calcium ion association with hydration indicated (Ca2+ with 3H2O).*

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

A line graph showing cumulative incidence (%) over time in years, comparing Atorvastatin calcium and placebo groups. The graph displays that the incidence for the Atorvastatin group increases at a slower rate than the placebo group. A hazard ratio (HR) of 0.64 (0.50-0.83) with a p-value of 0.0005 is noted, indicating statistical analysis results.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

A Kaplan-Meier cumulative hazard graph depicting time to first primary endpoint over four years of follow-up comparing Atorvastatin and placebo groups. The y-axis shows cumulative hazard percentage, and the x-axis shows years of follow-up. The graph includes hazard ratio (HR 0.63) with confidence intervals and a p-value (0.001), illustrating lower cumulative hazard with Atorvastatin versus placebo.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

A line graph depicting the percentage of subjects experiencing an event over time in years, comparing 10 mg and 80 mg doses of Atorvastatin. The y-axis shows subjects (%) experiencing events, while the x-axis shows time to first major cardiovascular endpoint up to 5 years. Two lines represent Atorvastatin 10 mg (dashed) and 80 mg (solid), with an annotation of hazard ratio (HR) 0.78 and p-value 0.0002.*

FDA Label Image

Atorvastatin-10mg-90s-tab-2 (Atorvastatin 10mg 90s Tab 2)

Label for Atorvastatin Calcium Tablets, USP 10 mg film-coated tablets, with a count of 90 tablets. The label includes storage instructions, manufacturer Alkem Laboratories Ltd., and distributor Ascend Laboratories, LLC information. The product is Rx only and includes a barcode and a patient information web link.*

FDA Label Image

Atorvastatin-20mg-500s-tab-2 (Atorvastatin 20mg 500s Tab 2)

Atorvastatin Calcium Tablets, USP 20 mg film-coated tablet label from Ascend Laboratories, LLC. The label specifies the dosage strength of 20 mg and a package count of 500 tablets. It includes storage instructions, manufacture and distribution information, a barcode, and a note for patient information access. The label also features regulatory and usage disclaimers.*

FDA Label Image

Atorvastatin-40mg-1000s-tab-2 (Atorvastatin 40mg 1000s Tab 2)

Label for Atorvastatin Calcium Tablets, USP 40 mg film-coated tablets. The label indicates an Rx only human prescription drug supplied in a package of 1000 tablets. It is manufactured by Alkem Laboratories Ltd. (India) and distributed by Ascend Laboratories, LLC (Bedminster, NJ). Storage instructions and other regulatory information are also included.*

FDA Label Image

Atorvastatin-80mg-1000s-tab-2 (Atorvastatin 80mg 1000s Tab 2)

Label for Atorvastatin Calcium Tablets, USP 80 mg film-coated tablets. The label indicates it contains 1000 tablets and is for prescription use only. Manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC. The label includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.